Month: March 2022

Orphazyme A/SCompany announcementNo. 11/2022www.orphazyme.comCompany Registration No. 32266355Copenhagen, Denmark, March 18, 2022 – Orphazyme A/S (ORPHA.CO; ORPH) (“Orphazyme” or the “Company”), a late-stage biopharmaceutical company, announces that following the Company’s filing of a petition for an in-court restructuring (in Danish rekonstruktion) of Orphazyme on March 10, 2022 (please see company announcement no. 10/2022), the Danish Maritime and Commercial High Court (the “Court”) has commenced the restructuring proceedings of the Company on March 11, 2022 at 7:00 am (CET). The Court has appointed attorney John Sommer Schmidt as restructuring administrator. The restructuring administrator has sent a notice of commencement of in-court restructuring proceedings of Orphazyme to all known creditors in accordance with section 11 b of...

ORO VALLEY, Ariz., March 18, 2022 (GLOBE NEWSWIRE) — Tautachrome (OTC:TTCM) eyes a dual listing as project development milestones are reached. Tautachrome securities have traded on the OTC Markets since closing the 2015 merger, while development work on the company’s intellectual and proprietary technology has taken place. In late February the company began expanding corporate development areas starting with integrity defense actions. Through this process the stability of the company’s public traded securities on OTC Markets came under review. Former advancement official, Micheal Nugent, opened dialogue with the board of directors to investigate a dual listing adding Tautachrome securities as trading instruments to a full auction exchange, aiming to gain transparency in trades reflecting actual interest sentiment in the security. OTC...

The shareholders in Bufab AB (publ), Reg. No. 556685-6240, are hereby invited to attend the Annual General Meeting, which will be held on Thursday 21 April 2022, at 10.30 a.m., at Vandalorum, Skulpturvägen 2, Värnamo. The Board of Directors has decided that shareholders shall be able to exercise their voting rights at the Annual General Meeting also by postal voting in accordance with the regulations in Bufab’s Articles of Association. A. RIGHT TO ATTEND THE ANNUAL GENERAL MEETING A.1 Participation in the meeting roomShareholders who intend to attend the meeting room in person or through a representative must:be registered in the register of shareholders as maintained by Euroclear Sweden AB on Monday 11 April 2022; and notify the Company of their intention to participate no later than on Wednesday 13 April 2022, by mail to Bufab...

SAN JUAN CAPISTRANO, Calif., March 18, 2022 (GLOBE NEWSWIRE) — The Ensign Group, Inc. (NASDAQ: ENSG), the parent company of the EnsignTM group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it has declared a quarterly cash dividend of $0.055 per share of Ensign common stock, payable on or before April 30, 2022, to shareholders of record as of March 31, 2022. Ensign has been a dividend-paying company since 2002. About Ensign™ The Ensign Group, Inc.’s independent operating subsidiaries provide a broad spectrum of skilled nursing and senior living services, physical, occupational and speech therapies and other rehabilitative and healthcare services at 250 healthcare...

Benuvia, a leading drug developer focused on pharmaceutical cannabinoids has entered into a definitive business combination agreement with Pono Capital Corp (Nasdaq: PONOU) The transaction implies a combined company pro forma enterprise value of $440 million Benuvia owns SYNDROS®, the FDA approved dronabinol (THC) oral solution, CII, which is approved for chemotherapy–induced nausea and vomiting in cancer patients and loss of appetite in AIDS patients who have lost weight, and is pursuing three additional INDs based on the same formulation as SYNDROS® Benuvia manufactures active pharmaceutical ingredients in its 83,000 square foot manufacturing facility that is permitted by the US DEA for Schedule I to III Controlled Substances, and is FDA registered and a cGMP facility Benuvia expects to receive up to $115 million in estimated...

GUANGZHOU, China, March 18, 2022 (GLOBE NEWSWIRE) — Puyi Inc. (“Puyi” or the “Company”) (NASDAQ: PUYI), a leading third-party wealth management service provider in China focusing on affluent and emerging middle class population, today announced that it will release its unaudited financial results for the first half of its fiscal year 2022 ended December 31, 2021 on March 28, 2022. Senior management will host a bilingual conference call in English and Chinese to discuss the Company’s unaudited financial results and business development for the first half of its fiscal year 2022 ended December 31, 2021. Details for the conference call are as follows:Date/Time: Monday, March 28, 2021 at 9:00 PM U.S. Eastern Daylight Time  (Tuesday, March 29, 2021 at 9:00 AM Beijing/Hong Kong Time)   Conference Title: Puyi Inc. Six Months...

VANCOUVER, British Columbia, March 18, 2022 (GLOBE NEWSWIRE) — Minto Metals Corp. (TSXV:MNTO) has reported assays from its 2021 drilling program in the Yukon. Minto owns and operates the producing Minto mine located in the Minto Copper Belt of the Yukon, Canada, which has been in operation since 2007 with underground mining commencing in 2014. Since 2007, approximately 500 million lbs of copper have been produced from the Minto mine. A Media Snippet accompanying this announcement is available by clicking on the image or link below:For more information, please view the InvestmentPitch Media video which provides additional information about this news and the company. The video is available for viewing on “InvestmentPitch.com” and on “YouTube”. If these links are not enabled, please visit www.InvestmentPitch.com and enter “Minto...

Shareholders in Elanders AB (publ) are invited to attend the Annual General Meeting to be held on Thursday April 21, 2022 at 11.00 a.m. at Södra Porten Conference, Flöjelbergsgatan 1 C, Mölndal. RIGHT TO PARTICIPATEShareholders who wish to attend the Annual General Meeting must be recorded in the register of shareholders maintained by Euroclear Sweden AB on Monday April 11, 2022. In addition, shareholders must notify the company of their intention to participate in the Meeting by latest April 13, 2022. In order to be entitled to participate in the meeting, shareholders who have trustee-registered their shares must, in addition to notify its intention to participate in the meeting, re-register the shares with Euroclear Sweden AB in their own name in order for the shareholder to be registered in shareholders’ register as of April 11, 2022....

SHENZHEN, China, March 18, 2022 (GLOBE NEWSWIRE) — Huize Holding Limited, (“Huize”, the “Company” or “we”) (NASDAQ: HUIZ), a leading digital insurance product and service platform for new generation consumers in China, today announced that its Board of Directors (“the Board”) has authorized a share repurchase program under which Huize may repurchase up to US$5 million of its Class A common shares in the form of American depositary shares over the next 12 months, subject to relevant rules under the Securities Exchange Act of 1934, as amended, and Huize’s insider trading policy. Mr. Cunjun Ma, Chairman and Chief Executive Officer of Huize, commented, “The Board’s decision to authorize the share repurchase program is aligned with our commitment to return value to our shareholders and reflects the confidence we have in Huize’s long-term...